Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Developmental Candidates for Cell-Based Therapies for Parkinson’s Disease (PD)

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Parkinson's Disease (PD) is a devastating disorder, stealing vitality from vibrant, productive adults & draining our health care dollars. It is also an excellent model for studying other neurodegenerative conditions.…

Continue ReadingDevelopmental Candidates for Cell-Based Therapies for Parkinson’s Disease (PD)

Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation

  • Post author:
  • Post published:May 20, 2025
  • Post category:

The clinical application of cell replacement therapy in the US is dependent on the FDA's approval, and the primary objective of the FDA is to protect patients from unsafe drugs…

Continue ReadingEnsuring the safety of cell therapy: a quality control pipeline for cell purification and validation

Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Human embryonic stem cells (hESC), and other related pluripotent stem cells, have great potential as starting material for the manufacture of curative cell therapies. This is primarily for two reasons.…

Continue ReadingMethods for detection and elimination of residual human embryonic stem cells in a differentiated cell product

Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Alzheimer disease (AD), the most common cause of dementia among the elderly and the third leading cause of death, presently afflicts over 5 million people in the USA, including over…

Continue ReadingNeural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease

Engineered immune tolerance by Stem Cell-derived thymic regeneration

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Stem cell therapies have the potential to transform medicine by allowing the regeneration of tissues or organs damaged by disease or trauma. In order for stem cell therapies to proceed,…

Continue ReadingEngineered immune tolerance by Stem Cell-derived thymic regeneration

Thymus based tolerance to stem cell therapies

  • Post author:
  • Post published:May 20, 2025
  • Post category:

This proposal focuses on the role of the immune system in transplantation of derivatives of human pluripotent stem cells (hPSCs). A critical roadblock to successful cell replacement therapies, no matter…

Continue ReadingThymus based tolerance to stem cell therapies
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us